Your browser doesn't support javascript.
loading
Multiple ways of C/EBPalpha inhibition in myeloid leukaemia.
Trivedi, A K; Pal, P; Behre, G; Singh, S M.
Afiliación
  • Trivedi AK; Drug Target Discovery and Development Division, Central Drug Research Institute (CDRI), Lucknow 226001, India. arun3vedi@cdri.res.in
Eur J Cancer ; 44(11): 1516-23, 2008 Jul.
Article en En | MEDLINE | ID: mdl-18515086
ABSTRACT
Transcription factors play a crucial role in myeloid differentiation and lineage determination. Tumour suppressor protein C/EBPalpha is a key regulator of granulocytic differentiation whose functional inactivation has become a pathophysiological signature of myeloid leukaemia. In this review we describe various mechanisms such as antagonistic protein-protein interaction, mutation and posttranslational modifications of C/EBPalpha which lead to its transcriptional inhibition and render C/EBPalpha inactive in its functions.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide / Proteína alfa Potenciadora de Unión a CCAAT / Mutación Tipo de estudio: Prognostic_studies Idioma: En Revista: Eur J Cancer Año: 2008 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide / Proteína alfa Potenciadora de Unión a CCAAT / Mutación Tipo de estudio: Prognostic_studies Idioma: En Revista: Eur J Cancer Año: 2008 Tipo del documento: Article